hexadecyl-p-tolyl ether | 57792-42-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: hexadecyl-p-tolyl ether
• 英文别名: Hexadecyl-p-tolyl-aether；1-p-Tolyloxy-hexadecan；4-Hexadecyloxy-toluol；Hexadecyl 4-methylphenyl ether；1-hexadecoxy-4-methylbenzene
• CAS: 57792-42-4
• 化学式: C₂₃H₄₀O
• 分子量: 332.57
• InChiKey: JXQLLDIJHXJEII-UHFFFAOYSA-N

物化性质

• 熔点：
  42.5 °C
• 沸点：
  426.8±14.0 °C(Predicted)
• 密度：
  0.881±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  10.1
• 重原子数：
  24
• 可旋转键数：
  16
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.74
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  hexadecyl-p-tolyl ether 在 1,4-二氧六环 、 镍 作用下， 生成 hexadecyl-(4-methyl-cyclohexyl)-ether
  参考文献：
  名称：

  The Selective Hydrogenation of Derivatives of Naphthalene and Diphenyl

  摘要：

  DOI：

  10.1021/ja01270a049
• 作为产物：
  描述：

  碘十六烷 、 sodium 4-methylphenoxide 生成 hexadecyl-p-tolyl ether
  参考文献：
  名称：

  The Selective Hydrogenation of Derivatives of Naphthalene and Diphenyl

  摘要：

  DOI：

  10.1021/ja01270a049

文献信息

• [EN] A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION D'INTERMÉDIAIRES DE TRIAZINE ET PROCÉDÉ DE PRÉPARATION D'ABSORBEURS UV ASSOCIÉS
  申请人：BASF SE

  公开号：WO2020144093A1

  公开（公告）日：2020-07-16

  The presently claimed invention relates to a novel, highly efficient and general process for the preparation of the triazine intermediates and their use in the preparation of UV absorbers.

  目前所声称的发明涉及一种新颖、高效和通用的三嗪中间体制备过程及其在制备紫外线吸收剂中的应用。
• GLYCOSIDE COMPOUND AND PREPARATION METHOD THEREFOR, COMPOSITION, APPLICATION, AND INTERMEDIATE
  申请人：Shanghai Hutchison Pharmaceuticals Limited

  公开号：EP3819303A1

  公开（公告）日：2021-05-12

  The present invention discloses a glycoside compound represented by Formula III, and a preparation method, a composition, use and an intermediate thereof. The glycoside compound provided in the present invention has simple preparation method, can significantly increase the expression of VEGF-A mRNA, and is effective in promoting the angiogenesis. This provides a reliable guarantee for the development of drugs with pro-angiogenic activity for treating cerebral infarction cerebral stroke, myocardial infarction, and ischemic microcirculatory disturbance of lower limbs.

  本发明公开了一种由式 III 表示的糖苷化合物及其制备方法、组合物、用途和中间体。本发明提供的苷类化合物制备方法简单，能显著提高血管内皮生长因子-A mRNA的表达，有效促进血管生成。这为开发治疗脑梗塞脑中风、心肌梗塞、下肢缺血性微循环障碍等具有促血管生成活性的药物提供了可靠保证。
• Alkoxylated p-phenylenevinylene oligomers: Synthesis and spectroscopic and electrochemical properties
  作者：Henri Ndayikengurukiye、Sven Jacobs、Wim Tachelet、Johan Van Der Looy、Anne Pollaris、Herman J. Geise、Magda Claeys、Jean M. Kauffmann、Silvia Janietz

  DOI：10.1016/s0040-4020(97)00871-5

  日期：1997.10

  Twenty-one n-alkoxy substituted phenylenevinylene oligomers were synthesized, varying in size, number and position of the OR groups. IR,MS and solubility data are presented. NMR measurements provided the molecular structure as well as information about conformations and molecular dynamics. UV and of cyclic voltammetric data give correlations of chemical structure (number and position of OR substituents) with separate HOMO and LUMO energies. (C) 1997 Elsevier Science Ltd.
• 373. Sulphonates of higher alkyl phenolic ethers
  作者：G. Spencer Hartley

  DOI：10.1039/jr9390001828

  日期：——
• A PROCESS FOR THE PREPARATION OF TRIAZINE INTERMEDIATES AND A PROCESS FOR THE PREPARATION OF UV ABSORBERS THEREOF
  申请人：BASF SE

  公开号：EP3908633A1

  公开（公告）日：2021-11-17